A share price of Precision Biosciences Inc [DTIL] is currently trading at $10.88, up 3.13%. An important factor to consider is whether the stock is rising or falling in short-term value. The DTIL shares have gain 12.28% over the last week, with a monthly amount glided 13.69%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Precision Biosciences Inc [NASDAQ: DTIL] stock has seen the most recent analyst activity on April 30, 2024, when Guggenheim initiated its Buy rating and assigned the stock a price target of $19. Previously, BMO Capital Markets started tracking the stock with Outperform rating on June 17, 2022, and set its price target to $7. On June 09, 2022, downgrade downgraded it’s rating to Mkt Perform. Goldman downgraded its rating to a Neutral and reduced its price target to $7 on April 03, 2020. Stifel started tracking with a Buy rating for this stock on March 05, 2020, and assigned it a price target of $21. In a note dated February 25, 2020, William Blair initiated an Outperform rating.
Precision Biosciences Inc experienced fluctuations in its stock price throughout the past year between $8.25 and $19.43. Currently, Wall Street analysts expect the stock to reach $15.5 within the next 12 months. Precision Biosciences Inc [NASDAQ: DTIL] shares were valued at $10.88 at the most recent close of the market. An investor can expect a potential return of 42.46% based on the average DTIL price forecast.
Analyzing the DTIL fundamentals
Trailing Twelve Months sales for Precision Biosciences Inc [NASDAQ:DTIL] were 87.64M which represents 152.15% growth. Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at -0.08%, Pretax Profit Margin comes in at 0.18%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.42 and Total Capital is -0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.41.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.55 points at the first support level, and at 10.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.14, and for the 2nd resistance point, it is at 11.41.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Precision Biosciences Inc [NASDAQ:DTIL] is 4.37. On the other hand, the Quick Ratio is 4.37, and the Cash Ratio is 3.75. Considering the valuation of this stock, the price to sales ratio is 0.50, the price to book ratio is 1.04.
Transactions by insiders
Recent insider trading involved Scimeca Dario, General Counsel and Secretary, that happened on Jun 10 ’24 when 93.0 shares were sold. Chief Research Officer, SMITH J. JEFFERSON completed a deal on Jun 10 ’24 to sell 50.0 shares. Meanwhile, General Counsel and Secretary Scimeca Dario sold 272.0 shares on May 02 ’24.
